SPOTLIGHT -
News
Article
Author(s):
Expiring on May 20, 2024, this CME discusses how to apply several novel treatment approaches in the treatment of patients with bipolar depression. Here are 5 key takeaways.
SPN-820 Fails to Meet Primary Endpoint in Study of Adults with Treatment-Resistant Depression
Blue Light Blockers: A Behavior Therapy for Mania
Mania and Hypomania: Latest Thinking on Diagnosis and Duration of Episodes
Treating ‘Morally Objectionable’ Patients
Major Depressive Disorder Research Roundup: February 6, 2025
Positive Results in Phase 2b Trial of Psychedelic Agent GH001 for Treatment-Resistant Depression